SCHEMBL1374982

SCHEMBL1374982

CC(=O)C(N=Nc1ccc(C(=O)Nc2ccc(C(N)=O)cc2)cc1)C(=O)Nc1ccc2[nH]c(=O)[nH]c2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.47
KDM4E B2RXH2 3/20 0.47
TP53 P04637 1/20 0.47
MAPK1 P28482 1/20 0.47
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
LMNA P02545 1/20 0.46
ALDH1A1 P00352 7/20 0.43
THRB P10828 1/20 0.43
RAB9A P51151 1/20 0.43
BCL6 P41182 1/20 0.41
BCOR Q6W2J9 1/20 0.41
KLK7 P49862 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PKM P14618 1/20 0.40
GAA P10253 1/20 0.40
XDH P47989 1/20 0.40
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NOS1 P29475 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1374976 1.00 MAPT (0.47) MAPTKDM4ETP53MAPK1MEN1
SCHEMBL1374979 1.00 MAPT (0.47) MAPTKDM4ETP53MAPK1MEN1
SCHEMBL16326827 0.95 BCL6 (0.45) MAPTKDM4ETP53MAPK1MEN1
SCHEMBL16330289 0.95 BCL6 (0.45) MAPTKDM4ETP53MAPK1MEN1
SCHEMBL16326753 0.94 MAPT (0.46) MAPTKDM4ETP53MAPK1MEN1
SCHEMBL28900433 0.92 BCL6 (0.45) MAPTKDM4ETP53MAPK1MEN1
SCHEMBL21655355 0.88 MAPT (0.48) MAPTKDM4ETP53MAPK1MEN1
SCHEMBL23786268 0.88 MAPT (0.47) MAPTKDM4ETP53MAPK1MEN1
SCHEMBL12014052 0.88 MAPT (0.47) MAPTKDM4ETP53MAPK1MEN1
SCHEMBL16326754 0.87 MAPT (0.44) MAPTKDM4ETP53MAPK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 242 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4741463-A1 UV CURABLE COMPOSITIONS AND INKS AGFA NV (BE) 2026-05-13 EP claimed
US-20260097694-A1 FLEXIBLE COMPOSITE SHEET AND FLEXIBLE SEAT CUSHION INCLUDING THE SAME SU WEN YUAN (TW) 2026-04-09 US claimed
US-20260085203-A1 Pigmented Free Radical Curable Inkjet Inks AGFA NV (BE) 2026-03-26 US claimed
US-12552954-B2 Ink set and inkjet printing methods AGFA NV (BE) 2026-02-17 US claimed
EP-4655359-A1 SOFT PIGMENTED CONTINUOUS INK JET INK COMPOSITIONS Videojet Technologies, Inc. (US) 2025-12-03 EP claimed
US-20250346772-A1 SOFT PIGMENTED CONTINUOUS INK JET INK COMPOSITIONS VIDEOJET TECHNOLOGIES INC. (US) 2025-11-13 US claimed
US-12448533-B2 UV curable inkjet inks and inkjet printing methods AGFA NV (BE) 2025-10-21 US claimed
US-12404414-B2 Aqueous inkjet inks and inkjet printing methods AGFA NV (BE) 2025-09-02 US claimed
EP-4050073-B1 INK SET AND INKJET PRINTING METHODS AGFA NV (BE) 2025-07-16 EP claimed
EP-4578646-A2 INK SET AND DECORATIVE LAMINATE PANELS AGFA NV (BE) 2025-07-02 EP claimed
US-20220397837-A1 TWO-COMPONENT DEVELOPER AND IMAGE FORMING METHOD Konica Minolta, Inc. (JP) 2022-12-15 US claimed
CN-115335473-A UV curable inkjet ink set and inkjet printing method 爱克发有限公司 2022-11-11 CN claimed
CN-115298031-A Inkjet printing method and inkjet printing system 爱克发有限公司 2022-11-04 CN claimed
US-20220288931-A1 AQUEOUS INKS FOR MANUFACTURING DECORATIVE PANELS AGFA NV (BE) 2022-09-15 US claimed
EP-4050072-A1 MANUFACTURING METHODS OF DECORATIVE SURFACES AGFA NV (BE) 2022-08-31 EP claimed
EP-4050073-A1 INK SET AND INKJET PRINTING METHODS AGFA NV (BE) 2022-08-31 EP claimed
US-20220220329-A1 AQUEOUS INKJET INK SETS AGFA NV (BE) 2022-07-14 US claimed
EP-4001370-A1 AQUEOUS INKJET INKS AND INKJET PRINTING METHODS AGFA NV (BE) 2022-05-25 EP claimed
EP-3981846-A1 FREE RADICAL CURABLE INKJET INKS AND INKJET PRINTING METHODS AGFA NV (BE) 2022-04-13 EP claimed
CN-112940431-A Laser-induced fluorescence emission composition and patterned fluorescence emission method 四川大学 2021-06-11 CN claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260085203-A1 Pigmented Free Radical Curable Inkjet Inks LIG4, DCLRE1A, LIG1 MAPT 2138/4885KDM4E 851/4885TP53 1095/4885
US-20260097694-A1 FLEXIBLE COMPOSITE SHEET AND FLEXIBLE SEAT CUSHION INCLUDING THE SAME MACF1, FLI1, PSIP1 MAPT 904/4885KDM4E 3800/4885TP53 2532/4885
US-12552954-B2 Ink set and inkjet printing methods DOT1L, TYR, RB1 MAPT 844/4885KDM4E 118/4885TP53 1397/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.